Ongoing Research Programs Clause Samples
Ongoing Research Programs. As between the Parties, AstraZeneca shall be solely responsible for the Ongoing Research Programs in accordance with accepted pharmaceutical industry norms and ethical practices. It is understood that while AstraZeneca retains the right to complete or wind-down the Ongoing Research Programs in accordance with current commitments under the Ongoing Research Agreements, AstraZeneca shall not expand, extend, or modify (except with respect to wind-down of such Ongoing Research Agreement) the Ongoing Research Programs and/or Ongoing Research Agreements without advance, written consent from Licensee [***] AZD5153. AstraZeneca shall use reasonable efforts to provide Licensee with [***], consistent with Section 2.1.5 where AstraZeneca [***]. Any [***] pursuant to this Section 3.2.3 shall be deemed to be Confidential Information of AstraZeneca. For the avoidance of doubt, [***].
Ongoing Research Programs. Epix and MKG acknowledge that they are currently engaged in a single Research Program under the Collaboration Agreement which relates to albumin binding for second generation intravascular contrast agents, which Research [*] Omitted portions filed separately with the Securities and Exchange Commission. Program is more fully described in correspondence between Epix and MKG dated [*]. Unless otherwise agreed by Epix and MKG, Epix and MKG agree that there shall be no more than [*] Research Programs being conducted at any time. Unless otherwise agreed by Epix and MKG, should a research program concept be proposed and the Joint Steering Committee recommend that such concept could be added to the Program while [*] Research Programs are being conducted, any such recommended Research Program shall be delayed until [*] the ongoing Research Programs [*] been completed.